Literature DB >> 20547622

The effectiveness of long-term dietary therapy in the treatment of adult Refsum disease.

Eleanor J Baldwin1, F Brian Gibberd, Claire Harley, Margaret C Sidey, Michael D Feher, Anthony S Wierzbicki.   

Abstract

OBJECTIVE: To evaluate the long-term effectiveness of dietary therapy with regular dietetic reinforcement for adult Refsum disease.
METHODS: Retrospective case note analysis of records of plasma phytanic acid and hospital admission of 13 patients with adult Refsum disease who attended the specialist centre and repeatedly received dietary instruction for a minimum of 10 years.
RESULTS: Patients undergoing review had attended for 11-28 years totalling 237 years. Median baseline phytanic acid concentrations at presentation were 1631 (370-2911) micromol/l and declined by 89+/-11% to 85 (10-1325) micromol/l. Levels of phytanic acid were completely normalised (<30 micromol/l) in 30%; partially normalised (30-300 micromol/l) in 50% and remained >300 pmol/l in 15%. The time required for phytanic acid levels to halve was 44.2+/-15.9 months in patients compliant with diet. No patient required admission or plasmapheresis/apheresis during this period for acute neuro-ophthalmological complications despite occasional spikes in phytanic acid levels attributable to intercurrent illness, surgery, sudden weight loss or psychological illness.
INTERPRETATION: Dietary modification with regular reinforcement in Adult Refsum Disease can significantly reduce phytanic acid levels with time.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20547622     DOI: 10.1136/jnnp.2008.161059

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Seeing through their eyes: lived experiences of people with retinitis pigmentosa.

Authors:  M Prem Senthil; J Khadka; K Pesudovs
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

Review 2.  Ataxia.

Authors:  Umar Akbar; Tetsuo Ashizawa
Journal:  Neurol Clin       Date:  2015-02       Impact factor: 3.806

3.  Probing of metabolites in finely powdered plant material by direct laser desorption ionization mass spectrometry.

Authors:  Syed Ghulam Musharraf; Arslan Ali; M Iqbal Choudhary
Journal:  J Am Soc Mass Spectrom       Date:  2014-02-05       Impact factor: 3.109

Review 4.  An Overview of the Current State and the Future of Ataxia Treatments.

Authors:  Kimberly Tsu Kwei; Sheng-Han Kuo
Journal:  Neurol Clin       Date:  2020-02-27       Impact factor: 3.806

5.  Phytanic acid disturbs mitochondrial homeostasis in heart of young rats: a possible pathomechanism of cardiomyopathy in Refsum disease.

Authors:  Mateus Grings; Anelise Miotti Tonin; Lisiane Aurélio Knebel; Angela Zanatta; Alana Pimentel Moura; Carlos Severo Dutra Filho; Moacir Wajner; Guilhian Leipnitz
Journal:  Mol Cell Biochem       Date:  2012-04-15       Impact factor: 3.396

6.  Next-generation sequencing-based molecular diagnosis of 82 retinitis pigmentosa probands from Northern Ireland.

Authors:  Li Zhao; Feng Wang; Hui Wang; Yumei Li; Sharon Alexander; Keqing Wang; Colin E Willoughby; Jacques E Zaneveld; Lichun Jiang; Zachry T Soens; Philip Earle; David Simpson; Giuliana Silvestri; Rui Chen
Journal:  Hum Genet       Date:  2014-12-04       Impact factor: 4.132

Review 7.  Treatable inherited rare movement disorders.

Authors:  H A Jinnah; Alberto Albanese; Kailash P Bhatia; Francisco Cardoso; Gustavo Da Prat; Tom J de Koning; Alberto J Espay; Victor Fung; Pedro J Garcia-Ruiz; Oscar Gershanik; Joseph Jankovic; Ryuji Kaji; Katya Kotschet; Connie Marras; Janis M Miyasaki; Francesca Morgante; Alexander Munchau; Pramod Kumar Pal; Maria C Rodriguez Oroz; Mayela Rodríguez-Violante; Ludger Schöls; Maria Stamelou; Marina Tijssen; Claudia Uribe Roca; Andres de la Cerda; Emilia M Gatto
Journal:  Mov Disord       Date:  2017-09-01       Impact factor: 10.338

8.  Marked inhibition of Na+, K(+)- ATPase activity and the respiratory chain by phytanic acid in cerebellum from young rats: possible underlying mechanisms of cerebellar ataxia in Refsum disease.

Authors:  Estela Natacha Brandt Busanello; Ângela Zanatta; Anelise Miotti Tonin; Carolina Maso Viegas; Carmen Regla Vargas; Guilhian Leipnitz; César Augusto João Ribeiro; Moacir Wajner
Journal:  J Bioenerg Biomembr       Date:  2012-11-15       Impact factor: 2.945

9.  The Challenges of a Successful Pregnancy in a Patient with Adult Refsum's Disease due to Phytanoyl-CoA Hydroxylase Deficiency.

Authors:  Karolina M Stepien; Anthony S Wierzbicki; Bwee T Poll-The; Hans R Waterham; Christian J Hendriksz
Journal:  JIMD Rep       Date:  2016-08-13

10.  Therapies for ataxias.

Authors:  Laurence Martineau; Anne Noreau; Nicolas Dupré
Journal:  Curr Treat Options Neurol       Date:  2014-07       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.